Liraglutide
FDA Approved: * December 23, 2024Pharm Company: * HIKMA PHARMS
Category: Diabetes
Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, obesity, and chronic weight management.[5][6] In diabetes it is a less preferred agent compared to metformin.[5][7] Its effects on long-term health outcomes like heart disease and life expectancy are unclear.[5][8] It is given by injection under the skin.[5] Com... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Liraglutide 18 mg/3ml Subcutaneous Injection, Solution
NDC: 14403-3400
Labeler:
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)